Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

Market Cap	4.69B -38.5%
Revenue (ttm)	1.33B -6.2%
Net Income	114.44M +46.4%
EPS	0.56 +43.9%
Shares Out	196.11M
PE Ratio	42.71
Forward PE	n/a
Dividend	0.25 (1.04%)
Ex-Dividend Date	Jun 22, 2026

Volume	16,980,657
Open	21.17
Previous Close	25.30
Day's Range	21.17 - 25.35
52-Week Range	20.50 - 48.90
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,236
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002940

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -7.35% compared to the previous year's 1.54 billion. Earnings were 125.44 million, an increase of 56.15%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error